On April 15, 2024, MicroPort CardioFlow Medtech Corporation entered into the 2024 MP CardioAdvent Service Procurement Framework Agreement with MP CardioAdvent for a period from the date of the 2024 MP CardioAdvent Service Procurement Framework Agreement to December 31, 2025 (both days inclusive), pursuant to which, MP CardioAdvent will procure certain Services (as defined below) from the Company and its subsidiaries, joint ventures and associates excluding MP CardioAdvent. Duration: From the date of the 2024 MP CardioAdvent Service Procurement Framework Agreement to December 31, 2025 (both dates inclusive). Nature of the Transactions: MP CardioAdvent will procure certain supporting services for its R&D and commercialization activities, such as technical services, registration, clinical trials, quality control, supply chain and sales promotion, from the Company and its subsidiaries, joint ventures and associates, excluding MP CardioAdvent (the "Services").

Payment Terms: Payment arrangements will be negotiated by the parties and stated in individual implementation agreements.